Inactive Instrument

Medtronic, Inc. Stock price Nyse

Equities

US5850551061

Medical Equipment, Supplies & Distribution

End-of-day quote Nyse
- USD 0.00% Intraday chart for Medtronic, Inc.
Sales 2024 * 32.22B Sales 2025 * 33.58B Capitalization 111B
Net income 2024 * 4.42B Net income 2025 * 5.12B EV / Sales 2024 * 4.14 x
Net Debt 2024 * 22.29B Net Debt 2025 * 21.05B EV / Sales 2025 * 3.93 x
P/E ratio 2024 *
24.6 x
P/E ratio 2025 *
21.1 x
Employees -
Yield 2024 *
3.31%
Yield 2025 *
3.46%
Free-Float 99.96%
More Fundamentals * Assessed data
Transcript : Medtronic plc Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 08:00 AM
Advance Auto Parts to add three board members as activist investors take stake RE
Advance Auto Parts Has Cooperation Accord With Activist Investors Third Point, Saddle Point; Three Directors Named MT
Medtronic plc Presents New Clinical and Real-World Data on the MiniMed? 780G System from Around the World CI
Medtronic Board Authorizes Incremental $5 Billion for Buybacks; $1.9 Billion Remains Under March 2019 Repurchase Program MT
Medtronic Keeps Fiscal Q4 Cash Dividend at $0.69 a Share, Payable April 12 to Holders of Record March 22 MT
Medtronic plc Approves Cash Dividend for the Fourth Quarter of Fiscal Year 2024, Payable on April 12, 2024 CI
Medtronic plc announces an Increase in Equity Buyback. CI
Tranche Update on Medtronic plc's Equity Buyback Plan announced on June 23, 2017. CI
UBS Raises Medtronic Price Target to $75 From $72, Maintains Sell Rating MT
Deutsche Bank Adjusts Medtronic Price Target to $85 From $79, Maintains Hold Rating MT
Mizuho Securities Raises Price Target on Medtronic to $98 From $95, Maintains Buy Rating MT
Truist Securities Adjusts Price Target on Medtronic to $90 From $87, Keeps Hold Rating MT
Oppenheimer Raises Medtronic Price Target to $92 From $89, Maintains Perform Rating MT
Health Care Down After Medtronic Earnings -- Health Care Roundup DJ
More news
Managers TitleAgeSince
Chief Executive Officer 54 15-01-25
Director of Finance/CFO 58 16-05-31
Chief Operating Officer 60 21-03-31
Members of the board TitleAgeSince
Director/Board Member 62 12-12-31
Director/Board Member 70 06-12-31
Director/Board Member 68 14-12-31
More insiders
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Calendar
Related indices
More about the company
  1. Stock
  2. Equities
  3. Stock Medtronic plc
  4. Stock Medtronic, Inc. - Nyse